000			03965cam a2200397 i 4500
003			OSt
005			20240305192445.0
006			m |o d |
007			cr_|||||||||||
008			151019s2016 enk ob 001 0 eng
010			_a 2015041033
020			_a9781118924952 (ePub)
020			_a9781118924976 (Adobe PDF)
020			_z9781118912034 (pbk.)
040			_aDLC _beng _cDLC _erda _dDLC
042			_apcc
050	0	0	_aRC848.F3
060	1	0	_aWI 700
082	0	0	_a616.3/62 _223
245	0	0	_aClinical dilemmas in non-alcoholic fatty liver disease / _c[edited by] Roger Williams, Simon Taylor-Robinson.
264		1	_aChichester, West Sussex, UK ; _aHoboken, NJ : _bJohn Wiley & Sons Inc., _c2016.
300			_a1 online resource.
336			_atext _2rdacontent
337			_acomputer _2rdamedia
338			_aonline resource _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aHype or harm from fatty liver disease? / Stephen H Caldwell and Curt Argo -- Worldwide problem / Geoffrey Farrell and Philip Newsome -- Is insulin resistance the key motive for NAFLD? / Desmond Johnston -- Progression to cirrhosis is more likely in children with NAFLD? / Anil Dhawan -- NAFLD as cause of cryptogenic cirrhosis? / Jay Lefkowitch -- Is NAFLD different in absence of metabolic syndrome? / Yusuf Yilmaz -- Occurrence of noncirrhotic HCC in NAFLD / Stephen Harrison and Dawn Torres -- Fibrosis progression molecular pathways all important? / Anna-Mae Diehl and Dr Wing-Kin Syn -- Can fatty liver of NAFLD be distinguished from that of alcoholic liver disease? / David Kleiner and Elizabeth Brunt -- Are inflammasomes and intestinal microbiota relevant in disease progression to NASH? / M. Bilal Siddiqui, M. Shadab Siddiqui and Arun Sanyal -- Can genetic influence in non-alcoholic fatty liver disease be ignored? / Quentin Anstee -- Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events? / Soo Lim -- Is there a best method for diagnosis of NAFLD? / Vlad Ratziu -- Choice of non-invasive blood tests and FibroScan / Massimo Pinzani and Manolis Tsocatzis -- Are the guidelines AASLD, IASL, EASL and BSG of help? / Jean-Francois Dufour -- How to choose from different imaging modalities and screening techniques / Hero Hussain -- Are the pros outweighed by the cons of obtaining a liver biopsy? / Simon Taylor-Robinson and Jeremy Cobbold -- Screening for NAFLD in high risk population / Nader Lessan -- Balancing calorie restriction, exercise and weight reduction / Nicholas Finer -- Should physicians be prescribing, or patients self-medicating with Orlistat, vitamin E, vitamin D, insulin antagonist, Trental and coffee? / Brent Neuschwander-Tetri and Haripriya Maddur -- Does improvement in hepatic steatosis have a significant favourable effect on the metabolic syndrome, including diabetes? / Jukka Westerbacka -- What are the dangers as well as the true benefits of bariatric surgery? / Andrew Jenkinson -- Liver transplantation : what can it offer? / Roger Williams -- Molecular antagonists, leptin or other hormones in supplementing environmental factors? / Jeremy Tomlinson -- Use of antifibrotic agents in clinical practice / Jonathan Fallowfield -- Better understanding of early development and material influence? / Jude Oben -- Defining the role of metabolic physician / Nicholas Finer.
588			_aDescription based on print version record and CIP data provided by publisher.
650	1	2	_aNon-alcoholic Fatty Liver Disease. _938451
700	1		_aWilliams, Roger, _d1931- , _eeditor. _938452
700	1		_aTaylor-Robinson, Simon D., _eauthor. _938453
776	0	8	_iPrint version: _tClinical dilemmas in non-alcoholic fatty liver disease _dChichester, West Sussex ; Hoboken, NJ : John Wiley & Sons Inc., 2016 _z9781118912034 _w(DLC) 2015040510
906			_a7 _bcbc _corigcop _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cEB
999			_c6920 _d6920